Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FYX41
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,858
Award facts
- Contract value 100% obligated
- $37,858.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,858.00 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nucala 100 mg/ml syringes. The contract utilizes a firm fixed-price structure with an ultimate completion date of August 26, 2025, and does not employ a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
The DLA's pharmaceutical supply chain relies on vendors like DMS Pharmaceutical Group to distribute essential medications and biologics to military health facilities nationwide. Nucala, a biologic injection used in the treatment of severe asthma and eosinophil-related conditions, represents the type of specialized pharmaceutical product that supports the medical readiness of the armed forces. Through its SPE2DB IDC, DMS Pharmaceutical Group has established itself as a critical supplier of both branded and generic prescription drugs, vaccines, and specialty medications, enabling rapid fulfillment of federal healthcare requirements across distributed military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FYX41?
SPE2DB25FYX41 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FYX41 worth?
The government has obligated $37,858 on SPE2DB25FYX41.
Is contract SPE2DB25FYX41 an order under another contract?
Yes. SPE2DB25FYX41 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX41 competed?
The extent of competition for SPE2DB25FYX41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award